Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China
Featured articles
Articles
-
-
Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?
-
DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease
-
In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use
-
Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications
-
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
-
Measles-mumps-rubella vaccination timing and autism among young african american boys: a reanalysis of CDC data
The Retraction Note to this article has been published in Translational Neurodegeneration 2014 3:22
-
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States
-
Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
-
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
The Correction to this article has been published in Translational Neurodegeneration 2023 12:2
Editor-in-Chief
Aims and Scope
Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.
Author posts: Behind the Paper
We welcome our authors to share the stories behind their research on Springer Nature Neuroscience Community.
Find out more about the research published in Translational Neurodegeneration by reading our authors' Behind the Paper posts.
Affiliated with
Annual Journal Metrics
-
2023 Citation Impact
10.8 - 2-year Impact Factor
11.6 - 5-year Impact Factor
2.374 - SNIP (Source Normalized Impact per Paper)
3.371 - SJR (SCImago Journal Rank)2023 Speed
8 days submission to first editorial decision for all manuscripts (Median)
111 days submission to accept (Median)2023 Usage
767,289 downloads
3,389 Altmetric mentions